Clinical Trial Update: Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA). [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (BASA) comparing low-dose (81 mg) versus high-dose (325 mg) aspirin for stroke outcomes in patients with blunt cerebrovascular injury i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blunt Cerebrovascular Injury

Drugs mentioned

• Aspirin 325 mg (acetylsalicylic acid)
• Aspirin 81 mg (acetylsalicylic acid)

Snippet

Sponsor: Loma Linda University | Conditions: Blunt Cerebrovascular Injury | Phase 4 | Status: RECRUITING